Immune-Related Adverse Events and Corticosteroid Use for Cancer-Related Symptoms Are Associated With Efficacy in Patients With Non-small Cell Lung Cancer Receiving Anti-PD-(L)1 Blockade Agents

Background: Immune-related adverse events (irAEs) have been associated with improved efficacy in advanced non-small cell lung cancer (NSCLC) patients receiving anti-PD-(L)1 blockade agents, while the concurrent use of corticosteroids seems to worsen it. We evaluated outcomes in advanced NSCLC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Riudavets, Mariona, Mosquera, Joaquin, Garcia-Campelo, Rosario, Serra, Jorgina, Anguera, Georgia, Gallardo, Pablo, Sullivan, Ivana, Barba, Andrés, del Carpio, Luís, Barnadas, Agustí, Gich, Ignasi, Majem, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505083/
https://www.ncbi.nlm.nih.gov/pubmed/33014837
http://dx.doi.org/10.3389/fonc.2020.01677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505083/
https://www.ncbi.nlm.nih.gov/pubmed/33014837
http://dx.doi.org/10.3389/fonc.2020.01677

Ejemplares similares